Sme-Migration (5)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Limited review report for Achyut Healthcare Limited's unaudited financial results for the half year ended September 30, 2025, submitted as … | |||||||||||||||
Limited review report for Achyut Healthcare Limited's unaudited financial results for the half year ended September 30, 2025, submitted as part of the company's migration from BSE SME to Mainboard platform.
| |||||||||||||||
Beta Drugs Limited's equity shares are being listed on the NSE Main Board following migration from the SME Emerge platform, with … | |||||||||||||||
Beta Drugs Limited's equity shares are being listed on the NSE Main Board following migration from the SME Emerge platform, with shareholding pattern as of November 13, 2025.
| |||||||||||||||
Shareholding pattern filing for Modis Navnirman Limited in connection with its migration from BSE SME platform to BSE Mainboard, showing … | |||||||||||||||
Shareholding pattern filing for Modis Navnirman Limited in connection with its migration from BSE SME platform to BSE Mainboard, showing promoter holding of 63.79% and public shareholding of 36.21%.
| |||||||||||||||
Shareholding pattern filing for Modis Navnirman Limited (Scrip Code: 543539) dated November 7, 2025, in connection with its migration from … | |||||||||||||||
Shareholding pattern filing for Modis Navnirman Limited (Scrip Code: 543539) dated November 7, 2025, in connection with its migration from BSE SME to BSE Mainboard.
| |||||||||||||||
BSE revises unified eligibility criteria for SME companies migrating to Main Board and companies from other exchanges seeking direct … | |||||||||||||||
BSE revises unified eligibility criteria for SME companies migrating to Main Board and companies from other exchanges seeking direct listing.
| |||||||||||||||